ConductScience.org, home

Paper6344896

Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.

Br J Clin Pharmacol, 1983. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function. Papers, record 6344896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6344896

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2019-05-11
PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycolatesMajor topic
HypertensionMajor topic
TicrynafenMajor topic
Uric AcidMajor topic
Adult
Aged
Body Weight
Clinical Trials as Topic
Creatinine
Electrolytes
Female
Humans
Liver Function Tests
Male
Middle Aged
Proteinuria
Urea

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1937359Renal transport of urate during diuretic-induced hypouricemia.Am J Med1976https://conductscience.org/library/papers/937359PubMed
2913063Mechanisms of the uricosuric effect of the diuretic tienilic acid (Ticrynafen) in man.Clin Sci Mol Med1977https://conductscience.org/library/papers/913063PubMed
3619301Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties.Nephron1978https://conductscience.org/library/papers/619301PubMed
4630794Ticrynafen, a uricosuric antihypertensive diuretic.Clin Pharmacol Ther1978https://conductscience.org/library/papers/630794PubMed
5648082Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid.Clin Pharmacol Ther1978https://conductscience.org/library/papers/648082PubMed
6348380Ticrynafen and hydrochlorothiazide in hypertension.Clin Pharmacol Ther1978https://conductscience.org/library/papers/348380PubMed
780525Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.Lancet1978https://conductscience.org/library/papers/80525PubMed
8359019A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension.Br J Clin Pharmacol1978https://conductscience.org/library/papers/359019PubMed
9372609Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossover.JAMA1979https://conductscience.org/library/papers/372609PubMed
10381954Renal function during therapy in patients with congestive cardiac failure. Ticrynafen vs. hydrochlorothiazide.Nephron1979https://conductscience.org/library/papers/381954PubMed
11381955Comparison of ticrynafen and probenecid in patients with elevated uric acid levels.Nephron1979https://conductscience.org/library/papers/381955PubMed
12381956Antihypertensive and hemodynamic effects of ticrynafen compared with hydrochlorothiazide.Nephron1979https://conductscience.org/library/papers/381956PubMed
13471153Comparative effects of ticrynafen and hydrochlorothiazide on blood pressure, renal function, serum uric acid and electrolytes, and body fluid spaces in hypertensive man.Nephron1979https://conductscience.org/library/papers/471153PubMed
14381957Renal function during ticrynafen therapy.Nephron1979https://conductscience.org/library/papers/381957PubMed
15492241Acute arthralgia (gout?) after tricrynafen.N Engl J Med1979https://conductscience.org/library/papers/492241PubMed
16492283Acute renal failure from ticrynafen.N Engl J Med1979https://conductscience.org/library/papers/492283PubMed
17492285Acute renal failure from ticrynafen.N Engl J Med1979https://conductscience.org/library/papers/492285PubMed
187351817Adverse reactions associated with ticrynafen use.JAMA1980https://conductscience.org/library/papers/7351817PubMed
197351819Acute renal failure during treatment with ticrynafen.JAMA1980https://conductscience.org/library/papers/7351819PubMed
207351824Ticrynafen's withdrawal from the market.JAMA1980https://conductscience.org/library/papers/7351824PubMed

See all 23 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
3884320Diuretics. Clinical pharmacology and therapeutic use (Part II).Drugs1985https://conductscience.org/library/papers/3884320

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6344896

GET https://conductscience.org/api/papers/v1/6344896/references?page=2